Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-Min Yan

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Cytotherapy|November 20, 2021
Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effectsLi Ding, Dong-Mei Han, Xiao-Li Zheng, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 27, 2017
[Clinical Study on Treatment of Juvenile Myelomonocytic Leukemia with Haploidentical-Hematopoietic Stem Cell Transplantation]Li Ding, Heng Zhu, Dong-Mei Han, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 3, 2015
[Unrelated Donor Peripheral Blood Stem Cell Transplantation Combined with Umbilical Cord Mesenchymal Stem Cells in Patients with Hematologic Malignancies]Xiao-Ting Zhang, Lian-Ning Duan, Li Ding, et al.
Stem Cells Translational Medicine|September 26, 2020
A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patientsLi Ding, Dong-Mei Han, Xiao-Li Zheng, et al.
Stem Cell Research & Therapy|March 19, 2020
Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacityLi Ding, Hong-Mei Ning, Pei-Lin Li, et al.
Leukemia Research|February 6, 2017
The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantationLi Ding, Heng Zhu, Yang Yang, et al.
Bone Marrow Transplantation|April 26, 2022
Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patientsLi Ding, Dong-Mei Han, Hong-Min Yan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2022
[Clinical Safety of NK Cell in the Prevention of Leukemia Relapse Post-transplantation and in Treatment of the Elderly Leukemia Patients]Jing Liu, Xiao-Li Zheng, Mei Xue, et al.
Leukemia & Lymphoma|November 5, 2013
Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplantLi Ding, Heng Zhu, Yang Yang, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Cytotherapy|November 20, 2021
Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effectsLi Ding, Dong-Mei Han, Xiao-Li Zheng, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 27, 2017
[Clinical Study on Treatment of Juvenile Myelomonocytic Leukemia with Haploidentical-Hematopoietic Stem Cell Transplantation]Li Ding, Heng Zhu, Dong-Mei Han, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 3, 2015
[Unrelated Donor Peripheral Blood Stem Cell Transplantation Combined with Umbilical Cord Mesenchymal Stem Cells in Patients with Hematologic Malignancies]Xiao-Ting Zhang, Lian-Ning Duan, Li Ding, et al.
Stem Cells Translational Medicine|September 26, 2020
A study of human leukocyte antigen-haploidentical hematopoietic stem cells transplantation combined with allogenic mesenchymal stem cell infusion for treatment of severe aplastic anemia in pediatric and adolescent patientsLi Ding, Dong-Mei Han, Xiao-Li Zheng, et al.
Stem Cell Research & Therapy|March 19, 2020
Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacityLi Ding, Hong-Mei Ning, Pei-Lin Li, et al.
Leukemia Research|February 6, 2017
The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantationLi Ding, Heng Zhu, Yang Yang, et al.
Bone Marrow Transplantation|April 26, 2022
Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patientsLi Ding, Dong-Mei Han, Hong-Min Yan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2022
[Clinical Safety of NK Cell in the Prevention of Leukemia Relapse Post-transplantation and in Treatment of the Elderly Leukemia Patients]Jing Liu, Xiao-Li Zheng, Mei Xue, et al.
Leukemia & Lymphoma|November 5, 2013
Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplantLi Ding, Heng Zhu, Yang Yang, et al.
Pageof 5